P3 Early evidence of antiviral activity and safety of ABX464 in HIV treatment-naïve patients

• Didier Scherrer,
• Jean-Marc Steens,
• Supparatpinyo Kuanchai,
• Ratanasuwan Winai,
• Kiat Ruxrungtham,
• Regine Rouzier,
• Jamal Tazi,
• Paul Gineste,
• Hartmut Ehrlich,
• Robert Murphy

Affiliations

Didier Scherrer

ABIVAX, Paris, France

Jean-Marc Steens

ABIVAX, Paris, France

Supparatpinyo Kuanchai

Chiang Mai University, Chiang Mai, Thailand

Ratanasuwan Winai

Siriraj Hospital, Bangkok, Thailand

Kiat Ruxrungtham

HIV-NAT, Chulalongkorn University Hospital, Bangkok, Thailand

Regine Rouzier

Cap Research, Phoenix, Mauritius

Jamal Tazi

University of Montpellier, Montpellier, France

Paul Gineste

ABIVAX, Paris, France

Hartmut Ehrlich

ABIVAX, Paris, France

Robert Murphy

Northwestern University Feinberg School of Medicine, Chicago, USA